|
|
||||||||
The Journal of Immunology, Vol 156, Issue 1 160-167, Copyright © 1996 by American Association of Immunologists
ARTICLES |
M Xia, D Leppert, SL Hauser, SP Sreedharan, PJ Nelson, AM Krensky and EJ Goetzl
Department of Medicine, University of California Medical Center, San Francisco 94143-0711, USA.
Chemotaxis of human T lymphoblastoma cells of the Tsup-1 line, which migrate similarly to blood T cells, through a layer of basement membrane-like Matrigel on a polycarbonate micropore filter was evoked by vasoactive intestinal peptide (VIP; concentration for a maximal response, 10(-7)M), IL-2 (10(-9)M), and the chemokines RANTES (10(- 10)M) and macrophage inflammatory protein-1 alpha (10(-10)M). Chemotactic concentrations of each factor increased Tsup-1 cell secretion of matrix metalloproteinase-9 (MMP-9), with significant responses by 4 h for VIP, IL-2, and IL-4, but only after 24 h for macrophage inflammatory protein-1 alpha and RANTES, as quantified by Western blots and zymography. 3H-Labeled type IV human collagen incorporated in the Matrigel layer was degraded by migrating Tsup-1 cells, as assessed by release of radioactive fragments of the collagen. The in situ degradation of type IV collagen in Matrigel by migrating Tsup-1 cells was enhanced most significantly by VIP, IL-2, and IL-4 after 4 h at concentrations that increased the secretion of MMP-9 optimally, but only after 24 h by macrophage inflammatory protein-1 alpha and RANTES. The specific MMP inhibitor GM6001 suppressed Tsup-1 cell MMP activity evoked by all stimuli, as determined by zymography and in situ degradation of 3H-Labeled type IV human collagen. The chemotactic migration of Tsup-1 cells through Matrigel, but not through a filter alone, in response to optimal concentrations of VIP, IL-2, and IL-4, but not the chemokines, was inhibited by GM6001, with a concentration dependence similar to that for suppression of MMP activity. Thus elicitation of T cell chemotactic migration through a model basement membrane by stimuli that increase MMP activity early in the response depends on degradation of matrix proteins by MMP, whereas stimuli that recruit MMP late may rely on early activation of other proteases.
This article has been cited by other articles:
![]() |
M. Ogawa, J.-i. Suzuki, K. Hishikari, K. Takayama, H. Tanaka, and M. Isobe Clarithromycin Attenuates Acute and Chronic Rejection Via Matrix Metalloproteinase Suppression in Murine Cardiac Transplantation J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1977 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Toft-Hansen, R. Buist, X.-J. Sun, A. Schellenberg, J. Peeling, and T. Owens Metalloproteinases Control Brain Inflammation Induced by Pertussis Toxin in Mice Overexpressing the Chemokine CCL2 in the Central Nervous System J. Immunol., November 15, 2006; 177(10): 7242 - 7249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzukawa, A. Komiya, M. Iikura, H. Nagase, C. Yoshimura-Uchiyama, H. Yamada, H. Kawasaki, K. Ohta, K. Matsushima, K. Hirai, et al. Trans-basement membrane migration of human basophils: role of matrix metalloproteinase-9 Int. Immunol., November 1, 2006; 18(11): 1575 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chabot, P. Reverdiau, S. Iochmann, A. Rico, D. Senecal, C. Goupille, P.-Y. Sizaret, and L. Sensebe CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9 J. Leukoc. Biol., April 1, 2006; 79(4): 767 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. G. Elkington, J. E. Emerson, L. D. C. Lopez-Pascua, C. M. O'Kane, D. E. Horncastle, J. J. Boyle, and J. S. Friedland Mycobacterium tuberculosis Up-Regulates Matrix Metalloproteinase-1 Secretion from Human Airway Epithelial Cells via a p38 MAPK Switch J. Immunol., October 15, 2005; 175(8): 5333 - 5340. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matias-Roman, B. G. Galvez, L. Genis, M. Yanez-Mo, G. de la Rosa, P. Sanchez-Mateos, F. Sanchez-Madrid, and A. G. Arroyo Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium Blood, May 15, 2005; 105(10): 3956 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Deem and J. M. Cook-Mills Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species Blood, October 15, 2004; 104(8): 2385 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grinninger, W. Wang, K. B. Oskoui, J. K. Voice, and E. J. Goetzl A Natural Variant Type II G Protein-coupled Receptor for Vasoactive Intestinal Peptide with Altered Function J. Biol. Chem., September 24, 2004; 279(39): 40259 - 40262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bar-Or, R. K. Nuttall, M. Duddy, A. Alter, H. J. Kim, I. Ifergan, C. J. Pennington, P. Bourgoin, D. R. Edwards, and V. W. Yong Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis Brain, December 1, 2003; 126(12): 2738 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sangaletti, A. Stoppacciaro, C. Guiducci, M. R. Torrisi, and M. P. Colombo Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma J. Exp. Med., November 17, 2003; 198(10): 1475 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Buchanan, D. Wang, F. Bargiacchi, and R. N. DuBois Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor J. Biol. Chem., September 12, 2003; 278(37): 35451 - 35457. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subramanian, A. Matejuk, A. Zamora, A. A. Vandenbark, and H. Offner Oral Feeding with Ethinyl Estradiol Suppresses and Treats Experimental Autoimmune Encephalomyelitis in SJL Mice and Inhibits the Recruitment of Inflammatory Cells into the Central Nervous System J. Immunol., February 1, 2003; 170(3): 1548 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Atkinson and R. M. Senior Matrix Metalloproteinase-9 in Lung Remodeling Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 12 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Voice, C. Grinninger, Y. Kong, Y. Bangale, S. Paul, and E. J. Goetzl Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice J. Immunol., January 1, 2003; 170(1): 308 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. GRAELER and E. J. GOETZL Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells FASEB J, December 1, 2002; 16(14): 1874 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mattos, S. Lim, R. Russell, A. Jatakanon, K. F. Chung, and P. J. Barnes Matrix Metalloproteinase-9 Expression in Asthma: Effect of Asthma Severity, Allergen Challenge, and Inhaled Corticosteroids Chest, November 1, 2002; 122(5): 1543 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Graeler, G. Shankar, and E. J. Goetzl Cutting Edge: Suppression of T Cell Chemotaxis by Sphingosine 1-Phosphate J. Immunol., October 15, 2002; 169(8): 4084 - 4087. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. F. Mosher, and D. D. Roberts Interactions of thrombospondins with {alpha}4{beta}1 integrin and CD47 differentially modulate T cell behavior J. Cell Biol., April 29, 2002; 157(3): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. McQuibban, G. S. Butler, J.-H. Gong, L. Bendall, C. Power, I. Clark-Lewis, and C. M. Overall Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1 J. Biol. Chem., November 16, 2001; 276(47): 43503 - 43508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. VOICE, G. DORSAM, H. LEE, Y. KONG, and E. J. GOETZL Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor FASEB J, November 1, 2001; 15(13): 2489 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Goetzl, J. K. Voice, S. Shen, G. Dorsam, Y. Kong, K. M. West, C. F. Morrison, and A. J. Harmar Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide PNAS, October 31, 2001; (2001) 241503798. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. P. Lindberg, C. J. A. De Groot, L. Montagne, P. Freitag, P. van der Valk, L. Kappos, and D. Leppert The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis Brain, September 1, 2001; 124(9): 1743 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brill, R. Hershkoviz, G. G. Vaday, Y. Chowers, and O. Lider Augmentation of RANTES-Induced Extracellular Signal-Regulated Kinase Mediated Signaling and T Cell Adhesion by Elastase-Treated Fibronectin J. Immunol., June 15, 2001; 166(12): 7121 - 7127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferland, M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system J. Leukoc. Biol., May 1, 2001; 69(5): 772 - 778. [Abstract] [Full Text] |
||||
![]() |
R. Gillitzer and M. Goebeler Chemokines in cutaneous wound healing J. Leukoc. Biol., April 1, 2001; 69(4): 513 - 521. [Abstract] [Full Text] |
||||
![]() |
Y. Zheng, Y. Kong, and E. J. Goetzl Lysophosphatidic Acid Receptor-Selective Effects on Jurkat T Cell Migration Through a Matrigel Model Basement Membrane J. Immunol., February 15, 2001; 166(4): 2317 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lane, S. Dias, K. Hattori, B. Heissig, M. Choy, S. Y. Rabbany, J. Wood, M. A. S. Moore, and S. Rafii Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases Blood, December 15, 2000; 96(13): 4152 - 4159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SUGA, K. IYONAGA, T. OKAMOTO, Y. GUSHIMA, H. MIYAKAWA, T. AKAIKE, and M. ANDO Characteristic Elevation of Matrix Metalloproteinase Activity in Idiopathic Interstitial Pneumonias Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1949 - 1956. [Abstract] [Full Text] |
||||
![]() |
A. Pagenstecher, A. K. Stalder, C. L. Kincaid, B. Volk, and I. L. Campbell Regulation of Matrix Metalloproteinases and Their Inhibitor Genes in Lipopolysaccharide-Induced Endotoxemia in Mice Am. J. Pathol., July 1, 2000; 157(1): 197 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Kim, R. P. Kitson, P. Albertsson, U. Nannmark, P. H. Basse, P. J. K. Kuppen, M. E. Hokland, and R. H. Goldfarb Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors J. Immunol., June 1, 2000; 164(11): 5883 - 5889. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Giraudon, R. Szymocha, S. Buart, A. Bernard, L. Cartier, M.-F. Belin, and H. Akaoka T Lymphocytes Activated by Persistent Viral Infection Differentially Modify the Expression of Metalloproteinases and Their Endogenous Inhibitors, TIMPs, in Human Astrocytes: Relevance to HTLV-I-Induced Neurological Disease J. Immunol., March 1, 2000; 164(5): 2718 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prat, L. Weinrib, B. Becher, J. Poirier, P. Duquette, R. Couture, and J. P. Antel Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis Neurology, December 1, 1999; 53(9): 2087 - 2087. [Abstract] [Full Text] |
||||
![]() |
J. Esparza, C. Vilardell, J. Calvo, M. Juan, J. Vives, A. Urbano-Marquez, J. Yague, and M. C. Cid Fibronectin Upregulates Gelatinase B (MMP-9) and Induces Coordinated Expression of Gelatinase A (MMP-2) and Its Activator MT1-MMP (MMP-14) by Human T Lymphocyte Cell Lines. A Process Repressed Through RAS/MAP Kinase Signaling Pathways Blood, October 15, 1999; 94(8): 2754 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kossakowska, D. R. Edwards, C. Prusinkiewicz, M. C. Zhang, D. Guo, S. J. Urbanski, T. Grogan, L. A. Marquez, and A. Janowska-Wieczorek Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Non-Hodgkin's Lymphomas Blood, September 15, 1999; 94(6): 2080 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette 5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104. [Abstract] [Full Text] |
||||
![]() |
A. Janowska-Wieczorek, L. A. Marquez, J.-M. Nabholtz, M. L. Cabuhat, J. Montano, H. Chang, J. Rozmus, J. A. Russell, D. R. Edwards, and A. R. Turner Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane Blood, May 15, 1999; 93(10): 3379 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wilkinson, J. J. T. Owen, and E. J. Jenkinson Factors Regulating Stem Cell Recruitment to the Fetal Thymus J. Immunol., April 1, 1999; 162(7): 3873 - 3881. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Goetzl, Y. Kong, and B. Mei Lysophosphatidic Acid and Sphingosine 1-Phosphate Protection of T Cells from Apoptosis in Association with Suppression of Bax J. Immunol., February 15, 1999; 162(4): 2049 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. JABRANE-FERRAT, D. BLOOM, A. WU, L. LI, D. LO, S. P. SREEDHARAN, C. W. TURCK, and A. E. J. GOETZL Enhancement by vasoactive intestinal peptide of {gamma}-interferon production by antigen-stimulated type 1 helper T cells FASEB J, February 1, 1999; 13(2): 347 - 353. [Abstract] [Full Text] |
||||
![]() |
C. Trocme, P. Gaudin, S. Berthier, C. Barro, P. Zaoui, and F. Morel Human B Lymphocytes Synthesize the 92-kDa Gelatinase, Matrix Metalloproteinase-9 J. Biol. Chem., August 7, 1998; 273(32): 20677 - 20684. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Kitson, P. M. Appasamy, U. Nannmark, P. Albertsson, M. K. Gabauer, and R. H. Goldfarb Matrix Metalloproteinases Produced by Rat IL-2-Activated NK Cells J. Immunol., May 1, 1998; 160(9): 4248 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aoudjit, E. F. Potworowski, and Y. St-Pierre Bi-Directional Induction of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 During T Lymphoma/Endothelial Cell Contact: Implication of ICAM-1 J. Immunol., March 15, 1998; 160(6): 2967 - 2973. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text] |
||||
![]() |
S. Okada, H. Kita, T. J. George, G. J. Gleich, and K. M. Leiferman Migration of Eosinophils through Basement Membrane Components In Vitro: Role of Matrix Metalloproteinase-9 Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 519 - 528. [Abstract] [Full Text] |
||||
![]() |
M. Xia, S. P. Sreedharan, D. R. Bolin, G. O. Gaufo, and E. J. Goetzl Novel Cyclic Peptide Agonist of High Potency and Selectivity for the Type II Vasoactive Intestinal Peptide Receptor J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 629 - 633. [Abstract] [Full Text] |
||||
![]() |
M. Stetler-Stevenson, A. Mansoor, M. Lim, P. Fukushima, J. Kehrl, G. Marti, K. Ptaszynski, J. Wang, and W. G. Stetler-Stevenson Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Reactive and Neoplastic Lymphoid Cells Blood, March 1, 1997; 89(5): 1708 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Goetzl, J. K. Voice, S. Shen, G. Dorsam, Y. Kong, K. M. West, C. F. Morrison, and A. J. Harmar Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide PNAS, November 20, 2001; 98(24): 13854 - 13859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. F. Mosher, and D. D. Roberts Interactions of thrombospondins with {alpha}4{beta}1 integrin and CD47 differentially modulate T cell behavior J. Cell Biol., April 29, 2002; 157(3): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |